Document Detail


Developmental and environmental epigenetic programming of the endocrine pancreas: consequences for type 2 diabetes.
MedLine Citation:
PMID:  23463236     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The development of the endocrine pancreas is controlled by a hierarchical network of transcriptional regulators. It is increasingly evident that this requires a tightly interconnected epigenetic "programme" to drive endocrine cell differentiation and maintain islet function. Epigenetic regulators such as DNA and histone-modifying enzymes are now known to contribute to determination of pancreatic cell lineage, maintenance of cellular differentiation states, and normal functioning of adult pancreatic endocrine cells. Persistent effects of an early suboptimal environment, known to increase risk of type 2 diabetes in later life, can alter the epigenetic control of transcriptional master regulators, such as Hnf4a and Pdx1. Recent genome-wide analyses also suggest that an altered epigenetic landscape is associated with the β cell failure observed in type 2 diabetes and aging. At the cellular level, epigenetic mechanisms may provide a mechanistic link between energy metabolism and stable patterns of gene expression. Key energy metabolites influence the activity of epigenetic regulators, which in turn alter transcription to maintain cellular homeostasis. The challenge is now to understand the detailed molecular mechanisms that underlie these diverse roles of epigenetics, and the extent to which they contribute to the pathogenesis of type 2 diabetes. In-depth understanding of the developmental and environmental epigenetic programming of the endocrine pancreas has the potential to lead to novel therapeutic approaches in diabetes.
Authors:
Ionel Sandovici; Constanze M Hammerle; Susan E Ozanne; Miguel Constância
Related Documents :
23733596 - L-cysteine and hydrogen sulfide increase pip3 and ampk/pparγ expression and decrease r...
24710966 - Tissue-specific dysregulation of cortisol regeneration by 11βhsd1 in obesity: has it p...
25025956 - Glucose-induced electrical activities and insulin secretion in pancreatic islet β-cell...
24772446 - Proinflammatory and prothrombotic state in subjects with different glucose tolerance st...
3514326 - Alterations in physiologic functions and in brain monoamine content in streptozocin-dia...
15113416 - Metabolic and cardiovascular improvements after biliopancreatic diversion in a severely...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review     Date:  2013-03-06
Journal Detail:
Title:  Cellular and molecular life sciences : CMLS     Volume:  70     ISSN:  1420-9071     ISO Abbreviation:  Cell. Mol. Life Sci.     Publication Date:  2013 May 
Date Detail:
Created Date:  2013-04-12     Completed Date:  2013-06-13     Revised Date:  2014-02-20    
Medline Journal Info:
Nlm Unique ID:  9705402     Medline TA:  Cell Mol Life Sci     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  1575-95     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Diabetes Mellitus, Type 2 / genetics*,  pathology
Epigenesis, Genetic*
Gene Expression Regulation, Developmental
Gene-Environment Interaction
Humans
Islets of Langerhans / growth & development*,  metabolism*,  pathology
Grant Support
ID/Acronym/Agency:
FS/09/029/27902//British Heart Foundation; //Biotechnology and Biological Sciences Research Council; //British Heart Foundation; //Medical Research Council

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Expanding roles for the evolutionarily conserved Dmrt sex transcriptional regulators during embryoge...
Next Document:  Bridging epigenomics and complex disease: the basics.